Practical Geriatrics ›› 2025, Vol. 39 ›› Issue (8): 851-856.doi: 10.3969/j.issn.1003-9198.2025.08.020
Previous Articles Next Articles
CHEN Jiayu, REN Binhui
Received:
2024-11-18
Online:
2025-08-20
Published:
2025-08-19
Contact:
REN Binhui, Email: renbinhui@jszlyy.com.cn
CLC Number:
CHEN Jiayu, REN Binhui. Advance of the mechanism of aging-related tumor metastasis[J]. Practical Geriatrics, 2025, 39(8): 851-856.
[1] SIEGEL R L, GIAQUINTO A N, JEMAL A. Cancer statistics, 2024 [J]. CA Cancer J Clin, 2024, 74(1): 12-49. [2] CHAFFER C L, WEINBERG R A. A perspective on cancer cell metastasis[J]. Science, 2011, 331(6024): 1559-1564. [3] GERSTBERGER S, JIANG Q, GANESH K. Metastasis [J]. Cell, 2023, 186(8): 1564-1579. [4] MANFIOLETTI G, FEDELE M. Epithelial-mesenchymal transition (EMT)[J]. Int J Mol Sci, 2023, 24(14): 11386. [5] IMRAN S A M, YAZID M D, IDRUS R B H, et al. Is there an interconnection between epithelial-mesenchymal transition (EMT) and telomere shortening in aging?[J]. Int J Mol Sci, 2021, 22(8): 3888. [6] FULOP T, LARBI A, PAWELEC G, et al. Immunology of aging: the birth of inflammaging[J]. Clin Rev Allergy Immunol, 2023, 64(2): 109-122. [7] RAO S G, JACKSON J G. SASP: tumor suppressor or promoter? yes![J]. Trends Cancer, 2016, 2(11): 676-687. [8] HAO Y, BAKER D, TEN DIJKE P. TGF-β-mediated epithelial-mesenchymal transition and cancer metastasis[J]. Int J Mol Sci, 2019, 20(11): 2767. [9] XU Q, MA H, CHANG H, et al. The interaction of interleukin-8 and PTEN inactivation promotes the malignant progression of head and neck squamous cell carcinoma via the STAT3 pathway[J]. Cell Death Dis, 2020, 11(5): 405. [10] ORTIZ-MONTERO P, LONDOÑO-VALLEJO A, VERNOT J P. Senescence-associated IL-6 and IL-8 cytokines induce a self- and cross-reinforced senescence/inflammatory milieu strengthening tumorigenic capabilities in the MCF-7 breast cancer cell line[J]. Cell Commun Signal, 2017, 15(1): 17. [11] JIA G, AROOR A R, JIA C, et al. Endothelial cell senescence in aging-related vascular dysfunction[J]. Biochim Biophys Acta Mol Basis Dis, 2019, 1865(7): 1802-1809. [12] WIELAND E, RODRIGUEZ-VITA J, LIEBLER S S, et al. Endothelial notch1 activity facilitates metastasis[J]. Cancer Cell, 2017, 31(3): 355-367. [13] ST SAUVER J L, WESTON S A, ATKINSON E J, et al. Biomarkers of cellular senescence and risk of death in humans[J]. Aging Cell, 2023, 22(12): e14006. [14] JIANG X, WANG J, DENG X, et al. The role of microenvironment in tumor angiogenesis[J]. J Exp Clin Cancer Res, 2020, 39(1): 204. [15] JI R C. The emerging importance of lymphangiogenesis in aging and aging-associated diseases[J]. Mech Ageing Dev, 2024, 221: 111975. [16] LIU Z, LIANG Q, REN Y, et al. Immunosenescence: molecular mechanisms and diseases[J]. Signal Transduct Target Ther, 2023, 8(1): 200. [17] CHEN A C Y, JAISWAL S, MARTINEZ D, et al. The aged tumor microenvironment limits T cell control of cancer[J]. Nat Immunol, 2024, 25(6): 1033-1045. [18] BRAUNING A, RAE M, ZHU G, et al. Aging of the immune system: focus on natural killer cells phenotype and functions[J]. Cells, 2022, 11(6): 1017. [19] REN J, LAN T, LIU T, et al. CXCL13 as a novel immune checkpoint for regulatory B cells and its role in tumor metastasis[J]. J Immunol, 2022, 208(10): 2425-2435. [20] PRIETO L I, STURMLECHNER I, GRAVES S I, et al. Senescent alveolar macrophages promote early-stage lung tumorigenesis[J]. Cancer Cell, 2023, 41(7): 1261-1275.e6. [21] ZHOU J, TANG Z, GAO S, et al. Tumor-associated macrophages: recent insights and therapies[J]. Front Oncol, 2020, 10: 188. [22] RYU S, SIDOROV S, RAVUSSIN E, et al. The matricellular protein SPARC induces inflammatory interferon-response in macrophages during aging[J]. Immunity, 2022, 55(9): 1609-1626.e7. [23] YANG C, WANG Z, LI L, et al. Aged neutrophils form mitochondria-dependent vital NETs to promote breast cancer lung metastasis[J]. J Immunother Cancer, 2021, 9(10): e002875. [24] SALMINEN A. Activation of immunosuppressive network in the aging process[J]. Ageing Res Rev, 2020, 57: 100998. [25] YE J, BAER J M, FAGET D V, et al. Senescent CAFs mediate immunosuppression and drive breast cancer progression[J]. Cancer Discov, 2024, 14(7): 1302-1323. [26] THEOCHARIS A D, SKANDALIS S S, GIALELI C, et al. Extracellular matrix structure[J]. Adv Drug Deliv Rev, 2016, 97: 4-27. [27] REN L L, MIAO H, WANG Y N, et al. TGF-β as a master regulator of aging-associated tissue fibrosis[J]. Aging Dis, 2023, 14(5): 1633-1650. [28] CUI N, HU M, KHALIL R A. Biochemical and biological attributes of matrix metalloproteinases[J]. Prog Mol Biol Transl Sci, 2017, 147: 1-73. [29] MARINO-BRAVANTE G E, CAREY A E, HÜSER L, et al. Age-dependent loss of HAPLN1 erodes vascular integrity via indirect upregulation of endothelial ICAM1 in melanoma[J]. Nat Aging, 2024, 4(3): 350-363. [30] BIANCHI-FRIAS D, DAMODARASAMY M, HERNANDEZ S A, et al. The aged microenvironment influences the tumorigenic potential of malignant prostate epithelial cells[J]. Mol Cancer Res, 2019, 17(1): 321-331. [31] PROVENZANO P P, INMAN D R, ELICEIRI K W, et al. Collagen density promotes mammary tumor initiation and progression[J]. BMC Med, 2008, 6: 11. [32] LEVI N, PAPISMADOV N, SOLOMONOV I, et al. The ECM path of senescence in aging: components and modifiers[J]. FEBS J, 2020, 287(13): 2636-2646. [33] WILEY C D, VELARDE M C, LECOT P, et al. Mitochondrial dysfunction induces senescence with a distinct secretory phenotype[J]. Cell Metab, 2016, 23(2): 303-314. [34] SONG B S, MOON J S, TIAN J, et al. Mitoribosomal defects aggravate liver cancer via aberrant glycolytic flux and T cell exhaustion[J]. J Immunother Cancer, 2022, 10(5): e004337. [35] LIBERTI M V, LOCASALE J W. The warburg effect: how does it benefit cancer cells?[J]. Trends Biochem Sci, 2016, 41(3): 211-218. [36] SULLIVAN L B, GUI D Y, HOSIOS A M, et al. Supporting aspartate biosynthesis is an essential function of respiration in proliferating cells[J]. Cell, 2015, 162(3): 552-563. [37] GAO A, LIU X, LIN W, et al. Tumor-derived ILT4 induces T cell senescence and suppresses tumor immunity[J]. J Immunother Cancer, 2021, 9(3): e001536. [38] CHEN L, ZHANG W, CHEN D, et al. RBM4 dictates ESCC cell fate switch from cellular senescence to glutamine-addiction survival through inhibiting LKB1-AMPK-axis[J]. Signal Transduct Target Ther, 2023, 8(1): 159. [39] GOMES A P, ILTER D, LOW V, et al. Age-induced accumulation of methylmalonic acid promotes tumour progression[J]. Nature, 2020, 585(7824): 283-287. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||
|